Impact of supplemental site grants to increase African American accrual for the selenium and vitamin e cancer prevention trial

Clinical Trials

Volumn 7, Issue 1, 2010, Pages 90-99

  Cook, Elise D ^a   Arnold, Kathryn B ^b   Hermos, John A ^c   McCaskill Stevens, Worta ^d   Moody Thomas, Sarah ^e   Probstfield, Jeffrey L ^f   Hamilton, Sandra J ^g   Campbell, Russell D ^h   Anderson, Karen B ^h   Minasian, Lori M ^d  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g MOREHOUSE SCHOOL OF MEDICINE   (United States)

^h USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; SELENIUM;

AFRICAN AMERICAN; ARTICLE; CANCER PREVENTION; CANCER RESEARCH; CANCER SCREENING; COMPARATIVE STUDY; CONTROLLED STUDY; FUNDING; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT PARTICIPATION; PATIENT SELECTION; PREVENTION STUDY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITATIVE ANALYSIS; QUANTITATIVE STUDY; STRATEGIC PLANNING;

AFRICAN AMERICANS; ANTIOXIDANTS; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NEOPLASMS; PATIENT SELECTION; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH SUPPORT AS TOPIC; SELENIUM; UNITED STATES; VITAMIN E;

EID: 77749289999     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774509357227     Document Type: Article

References (20)

1. American Cancer Society. Cancer Facts and Figures 2008. American Cancer Society, Atlanta, GA, 2008. Available at: http://www.cancer.org/docroot/stt/ content/stt-1x-cancer-facts-and-figures-2008.asp (accessed 25 March 2009).
2. American Cancer Society. Cancer Facts and Figures for African American 2009-2010. American Cancer Society, Atlanta, GA, 2009. Available at: http://www.cancer.org/docroot/STT/content/STT-1x-Cancer-Facts-Figures-for- African-Americans-2009-2010-09.asp (accessed 25 March 2009 ).
3. Ries LAG, Melbert D., Krapcho M., et al. SEER Cancer Statistics Review, 1975-2004, National Cancer Institute. Bethesda, MD Available at: http://seer.cancer.gov/csr/1975-2004/, based on November 2006 SEER data submission, posted to the SEER website, 2007 (accessed 14 December 2007).
4. Thompson IM, Tangen CM, Klein EA, Lippman SM Phase III prostate cancer prevention trials: are the costs justified? J Clin Oncol 2005 ; 23: 8161-8164.
5. Feigl P., Blumenstein B., Thompson I., et al. Design of the Prostate Cancer Prevention Trial (PCPT). Control Clin Trials 1995 ; 16: 150-163.
6. Moinpour CM, Atkinson JO, Thomas SM, et al. Minority recruitment in the prostate cancer prevention trial. Ann Epidemiol 2000 ; 10: S85-91.
7. Reynolds T. PCPT update: enrollment mounts, but minority participation lags. J Natl Cancer Inst 1994 ; 86: 1500-1501.
8. Coltman CA, Thompson IM, Feigl P. Prostate Cancer Prevention Trial (PCPT) update. Eur Urol 1999 ; 35: 544-547.
9. Swanson GM, Ward AJ Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst 1995 ; 87: 1747-1759.
10. Woods VD, Montgomery SB, Herring RP Recruiting black/African American men for research on prostate cancer prevention. Cancer 2004 ; 100: 1017-1025.
11. McCaskill-Stevens W., Pinto H., Marcus AC, et al. Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association. J Clin Oncol 1999 ; 17: 1029-1039.
12. Harris Y., Gorelick PB, Samuels P., Bempong I. Why African Americans may not be participating in clinical trials. J Natl Med Assoc 1996 ; 88: 630-634.
13. Millon-Underwood S., Sanders E., Davis M. Determinants of participation in state-of-the-art cancer prevention, early detection screening, and treatment trials among African-Americans. Cancer Nurs 1993 ; 16: 25-33.
14. Green BL, Partridge EE, Fouad MN, et al. African-American attitudes regarding cancer clinical trials and research studies: results from focus group methodology. Ethn Dis 2000 ; 10: 76-86.
15. Probstfield JL, Wittes JT, Hunninghake DB Recruitment in NHLBI population-based studies and clinical trials: data analysis and survey results. Control Clin Trials 1987 ; 8: 141S - 9S.
16. Paskett ED, DeGraffinreid CR, Tatum CM, Margitic SE The recruitment of African-Americans to cancer prevention and control studies. Prev Med 1996 ; 25: 547-553.
17. Probstfield JL The clinical trial pre-randomization compliance (adherence) screen. In: Cramer JA, Spilker B. (eds). Patient Compliance in Medical Practice and Clinical Trials. Raven Press, New York, 1991, pp. 323-334.
18. Lippman SM, Goodman PJ, Klein EA, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst 2005 ; 97: 94-102.
19. Oddone EZ, Olsen MK, Lindquist JH, et al. Enrollment in clinical trials according to patient's race: experience from the VA Cooperative Studies Program (1975-2000). Control Clin Trials 2004 ; 25: 378-387.
20. Cook ED, Moody-Thomas S., Anderson KB, et al. Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Clin Trials 2005 ; 2: 436-442.